Pretreatment of cells with 2, 5, and 10 μM of CPZ reduced PCV3 infection from 25.5% in the untreated cells to 19.5, 13.3, and 12.9%, respectively (Figures 2B,C). This evidence concerns the gene CPZ and infection.